Uses of Remdinil : Remdinil use as a treatment of Coronavirus disease (COVID-19). Indicated for the treatment of Coronavirus disease (COVID-19). Remdinil is not recommended for patients who have a known hypersensitivity to it.

Anti-viral drugs

Remdesivir is a nucleoside analog that is expected to inhibit the action of RNA polymerase. By incorporating into RNA, additional nucleotides cannot be added, terminating RNA transcription. Viruses with mutations in RNA polymerase to develop partial resistance to remdesivir have been shown to be less infective.

How to use Remdesivir: Remdesivir will be given via intravenous infusionto only.It will be given by a doctor or medical professional. Please avoid self-administration. Administration: It must be administered via intravenous infusion only. Do not administer by any other route.Recommended Rate of Infusion- Diluted Remdesivir for Injection Lyophilized Powder in Adults and Pediatric Patients Weighing > 40 kg Infusion bag 250 ml: Infusion Time: 30 min, Rate of Infusion: 8.33 ml/min Infusion Time: 60 min, Rate of Infusion: 4.17 ml/min Infusion Time: 120 min, Rate of Infusion: 2.08 ml/min Infusion bag 100 ml: Infusion Time: 30 min, Rate of Infusion: 3.33 ml/min Infusion Time: 60 min, Rate of Infusion: 1.67 ml/min Infusion Time: 120 min, Rate of Infusion: 0.83 ml/min Adult Dose: Adults requiring invasive mechanical ventilation and/or ECMO should receive a single loading dose of Remdesivir 200 mg on day one, followed by a once-daily maintenance dose of Remdesivir 100 mg for 9 days. The recommended dose for adults who do not require invasive mechanical ventilation or ECMO is a single dose of Remdesivir 200 mg on day one, followed by a once-daily maintenance dose of Remdesivir 100 mg for four days. If a patient dose does not show clinical improvement, treatment may be extended for up to 5 more days (for a total of 10 days). Remdesivir will be administered intravenously in a total volume of up to 250 mL 0.9% saline over 30 to 120 minutes. Child Dose: For patients weighing between 3.5 kg and 40 kg, calculate the mg/kg dose based on their weight. Renal Dose: Not recommended in patients with eGFR less than 30 mL per minute.

Due to antagonism observed in cell culture,chloroquine phosphate or hydroxychloroquine sulfate is not recommended use with remdesivir. There have been no human drug-drug interaction trials with it and other medications. Remdesivir and its metabolites can act as substrates or inhibitors of enzymes and transporters involved in drug metabolism in vitro. The clinical relevance of these in vitro assessments is not established.

Remdesivir is not recommended for patients who have a known hypersensitivity to it.

Common - Nausea - Vomiting - Diarrhea - Headaches - Rashes - Increased liver enzymes In clinical trials, elevated liver transaminases were observed as an adverse reaction to Remdesivir in healthy adult patients.

Pregnancy & Lactation Category Note: Pregnancy: It may be unsafe to take when pregnant. Although there have been few human research, animal studies have revealed negative impacts on the growing fetus.Before prescribing it to you, your doctor will consider the advantages and hazards.Please consult your doctor. Lactation: There is no information available about the presence of Remdesivir in human milk, the effects on breastfed infants, or the effects on milk production. Because of the risk of viral transmission of SARS-CoV-2 negative infants and adverse drug reactions in breastfeeding infants, the developmental and health benefits of breastfeeding should be considered alongside the mother's clinical need for Remdesivir and any potential adverse effects on the breastfed child from Remdesivir or the underlying maternal condition.

Precaution: Hypersensitivity, including infusion-related and anaphylactic reactions. Higher risk of transaminase elevations. Risk of decreased antiviral activity when combined with chloroquine phosphate or hydroxychloroquine sulfate. Hypersensitivity Including Infusion-related and Anaphylactic Reactions. Increased Risk of Transaminase Elevations. Risk of Reduced Antiviral Activity When Co-administered with Chloroquine Phosphate or Hydroxychloroquine Sulfate.

Please do not reuse or save any unused Remdesivir Lyophilized powder, injection solution, or diluted solution for infusion for future use. This product has no preservatives. Lyophilized Powder:Remdesivir for injection, 100 mg, vials should be stored at a temperature of no more than 30°C in a dry place until ready for use. Protect from light and moisture. Don't use after the expiration date. After reconstitution, vials can be kept at room temperature for up to 4 hours (20°C-25°C) or refrigerated for 24 hours (2°C-8°C). Please dilute on the same day as administration. Diluted Solution for Infusion: Should be stored at room temperature for up to 4 hours (20°C-25°C) or refrigerated for 24 hours (2°C-8°C).

Anti-viral drugs

It is a broad-spectrum antiviral medication. It works by inhibiting an RNA-dependent enzyme called RNA polymerase, which helps the SARS-CoV-2 virus replicate itself. This reduces the viral load in the body.

No adequate and well controlled studies of Remdesivir use in pregnant women have been conducted. Remdesivir should be used in pregnancy only if the potential benefit justifies the potential risk for the mother fetus. There is no information regarding the presence of Remdesivir in human milk, the effects on the breastfeed infants, or the effects on milk production. Because of the potential for viral transmission of SARS-CoV-2 negative infants and adverse reactions from the drug in breastfeeding infants, the development and health benefits of breastfeeding should be considered along with the mother's clinical need for Remdesivir and any potential adverse effects on the breastfed child from Remdesivir or from the underlying maternal condition.